The mechanism(s) involved in hepatobiliary transport of copper (Cu),1 essential for the maintenance of Cu homeostasis, are still unclear. It has been postulated that Cu is secreted into bile as a complex with glutathione (GSH) (1, 2) . Alternatively, data from clinical (for review see reference 3) as well as experimental (4) studies have been interpreted to suggest that biliary secretion of Cu occurs by lysosomal exocytosis. We have recently provided evidence that Cu can be transported into bile by at least two different pathways in rats. First, a GSH-dependent route appears to be active in the removal of Cu after i.v. injection of the metal (5, 6) . Second, a physiologically more important pathway independent of GSH is responsible for removal of "endogenous" or dietary copper (5) . For this latter pathway a maximal secretion rate of 30-35 nmol/h per 100 g body weight was found under different experimental conditions with widely varying hepatic Cu concentrations (7) . We have interpreted these results as indicative for the existence of a saturable Cu-transporting system in rat liver (7) . The recent identification of the gene responsible for Wilson disease, an autosomal recessive disorder of hepatobiliary Cu transport (8) , encoding for a P-type ATPase appears to be in line with this option (9) (10) (11) . However, so far no functional evidence for ATP-dependent Cu transport has been provided and the biochemical properties of this putative Cu-transporting system remain to be established.
In the present study, plasma membrane vesicles from rat liver were shown to take up Cu in an ATP-dependent manner by a transport system sensitive to vanadate, a well-established inhibitor of P-type ATPases (12) . The ATP-dependent Cutransporting system is distinct from the glutathione-conjugate transport system (cMOAT), which is defective in mutant Groningen Yellow (GY) rats (13 gous (9, 11) . In addition, the reported sequences show close homology to those of a variety of bacterial P-type ATPases implicated in heavy metal efflux (22) . In contrast to the Menkes disease gene, which shows expression in all body cells except the liver, the Wilson disease gene is predominantly expressed in liver, kidney and placenta. Until now, however, no biochemical evidence for ATP-dependent Cu transport in mammalian systems has been reported. In this study we provide biochemical evidence for the presence of an ATP-dependent transport system for Cu in isolated rat liver plasma membranes. In the presence of ATP (4 mM) and an ATP regenerating system, a clear ATP-dependent uptake of radiolabeled Cu (10 ,M) was measured in cLPM of normal Wistar rats (Fig. 1 A) . Initial Cu uptake rate in cLPM was 3-4 times higher than in control incubations containing AMP, indicating that an active ATP-dependent transport system is operating in these membrane preparations. This is in line with the interpretation of recent results from our laboratory, as suggesting the presence of a saturable transport system involved in hepatobiliary secretion of Cu in rats (7) . To verify that ATPdependent Cu uptake rather than binding was measured, studies were performed after 5 min incubation of the vesicles, with increasing concentrations of sucrose (0.25-1 M), which results in a decrease in the intravesicular volume. The amount of Cu taken up by vesicles decreased with increasing osmolarity of the extravesicular medium, indicating that Cu is transported into an osmotically active vesicular space. Extrapolation to an infinetely high medium osmolarity, i.e., a negligible intravesicular volume, revealed that 30% of the Cu associated with the vesicles could be attributed to membrane binding. The presence of EDTA in the stop buffer did not affect this aspecific binding. Vanadate, an inhibitor of P-type ATPases (12), inhibited Cu transport in a concentration-dependent fashion, as shown in Fig.  2 , indicating involvement of a P-type ATPase in this transport process. This is in accordance with the genetically obtained evidence for Menkes and Wilson disease (9) (10) (11) (19) (20) (21) . This vanadate effect suggests that y-phosphate transfer from ATP to the carrier is involved in the process of Cu transport. ATP-dependent Cu uptake showed saturation kinetics with an apparent Km value of 8.6 MM and a Vm,, of 6.9 nmol/min per mg protein (Fig. 3 /Lmol/h per mg protein in cLPM compared with 3.9 ymol/h per mg protein for blLPM, indicating that our blLPM preparations were contaminated for at least 10% with canalicular membranes. On the other hand, the ratio between the initial uptake rate in cLPM and blLPM of ATP-dependent Cu transport was lower than the value for ATP-dependent taurocholate transport, as shown in Table I . Thus, contamination with cLPM is not likely to be the (only) cause of the observed Cu uptake in blLPM preparations. Another possible explanation for the appearance of transport activity in both preparations used is that liver plasma membrane preparations are always contaminated to some extent with subcellular organelles ( 14) : the Cu-transport protein may also reside in a subcellular compartment, involved in hepatic disposition of Cu. Concerning the molecular mechanism of hepatobiliary Cu transport a role of lysosomes has been suggested by several authors (see reference 3 and references therein; 4). Therefore, the localisation of Cu-ATPase activity in subcellular organelle preparations is currently being investigated in our laboratory, as are matters concerning regulation and specificity of the transport system(s). The demonstration of Cu-ATPase activity in human liver and its absence in Wilson disease liver is required for unequivocal proof for the role of Cu-ATPase in the etiology of Wilson disease. Techniques are operational in our laboratory for the isolation of cLPM and b1LPM from human livers (14, 29) . So far, we have provided strong indications that a saturable ATP-dependent Cu transport system is present in isolated rat liver membranes.
